Home » Topics » Regulatory

Regulatory
RSS

Lilly's Zyprexa approved by FDA for extended schizophrenia indication

Nov. 15, 2000

Abbott submits Biaxin XL sNDA for CAP

Nov. 14, 2000

Pariet receives E.U. approval for H. pylori eradication in peptic ulcer disease

Nov. 14, 2000

Astelin Nasal Spray approved in U.S. for treatment of nonallergic vasomotor rhinitis

Nov. 10, 2000

Connetics' foam formulation for scalp dermatoses launched in U.S.

Nov. 9, 2000

Bayer seeks FDA approval for intravenous formulation of Avelox

Nov. 8, 2000

New three-in-one approach to Parkinson's disease

Nov. 8, 2000

Permax approved in Canada as monotherapy for PD

Nov. 8, 2000

DIRECT trial begins for prevention and progression of retinopathy in diabetic patients

Nov. 7, 2000

FDA approves once-daily Videx capsules

Nov. 3, 2000

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...